138 related articles for article (PubMed ID: 26908458)
1. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A
Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458
[TBL] [Abstract][Full Text] [Related]
2. Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
Xie X; Tang SC; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y
Oncotarget; 2016 Sep; 7(36):58111-58120. PubMed ID: 27517156
[TBL] [Abstract][Full Text] [Related]
3. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
Schlienger S; Ramirez RA; Claing A
Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.
Tsai MM; Lin PY; Cheng WL; Tsai CY; Chi HC; Chen CY; Tseng YH; Cheng YF; Chen CD; Liang Y; Liao CJ; Wu SM; Lin YH; Chung IH; Wang CS; Lin KH
Cancer Sci; 2012 Jun; 103(6):1136-44. PubMed ID: 22348287
[TBL] [Abstract][Full Text] [Related]
5. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.
Boulay PL; Cotton M; Melançon P; Claing A
J Biol Chem; 2008 Dec; 283(52):36425-34. PubMed ID: 18990689
[TBL] [Abstract][Full Text] [Related]
7. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
Lewis-Saravalli S; Campbell S; Claing A
Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
[TBL] [Abstract][Full Text] [Related]
8. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
[TBL] [Abstract][Full Text] [Related]
9. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein.
Boulay PL; Schlienger S; Lewis-Saravalli S; Vitale N; Ferbeyre G; Claing A
Oncogene; 2011 Sep; 30(36):3846-61. PubMed ID: 21478909
[TBL] [Abstract][Full Text] [Related]
10. The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
Haines E; Schlienger S; Claing A
Cancer Biol Ther; 2015; 16(10):1535-47. PubMed ID: 26176330
[TBL] [Abstract][Full Text] [Related]
11. SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin.
Kang GJ; Park MK; Byun HJ; Kim HJ; Kim EJ; Yu L; Kim B; Shim JG; Lee H; Lee CH
J Cell Physiol; 2020 Feb; 235(2):1543-1555. PubMed ID: 31313837
[TBL] [Abstract][Full Text] [Related]
12. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
13. ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion.
Schlienger S; Campbell S; Claing A
Mol Biol Cell; 2014 Jan; 25(1):17-29. PubMed ID: 24196838
[TBL] [Abstract][Full Text] [Related]
14. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
15. ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.
Davis JE; Xie X; Guo J; Huang W; Chu WM; Huang S; Teng Y; Wu G
Oncotarget; 2016 Jun; 7(26):39834-39845. PubMed ID: 27213581
[TBL] [Abstract][Full Text] [Related]
16. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM
Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587
[TBL] [Abstract][Full Text] [Related]
17. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
18. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
[TBL] [Abstract][Full Text] [Related]
19. Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.
Srinivasan A; Thangavel C; Liu Y; Shoyele S; Den RB; Selvakumar P; Lakshmikuttyamma A
Mol Carcinog; 2016 May; 55(5):743-56. PubMed ID: 25968914
[TBL] [Abstract][Full Text] [Related]
20. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
